Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review

Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bausch Health Companies Inc (Bausch Health) formerly known as Valeant Pharmaceuticals International Inc, manufactures, develops and markets range of medical devices, over-the-counter products (OTC) and pharmaceutical products. Bausch Health offers products in the areas of dermatology, gastroenterology and eye health. It also offers generic and branded generic products. Bausch Health offers products in various regions across the world including the US, Canada, Africa, Middle East, Australia, Latin America, and Europe. The company has manufacturing facilities worldwide. It manufactures products through third party sources. Bausch Health is headquartered in Laval, Quebec, Canada.

Bausch Health Companies Inc Key Recent Developments

May 06,2019: Bausch Health Companies announces first-quarter 2019 results and raises full-year guidance
Mar 01,2019: Synergy Pharmaceuticals receives court approval for the sale of its assets to Bausch Health
Feb 20,2019: Bausch Health Companies announces fourth-quarter and full-year 2018 results and provides 2019 guidance
Dec 14,2018: Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals
Nov 06,2018: Bausch Health Companies announces third-quarter 2018 esults

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
Bausch Health Companies Inc - Key Facts
Bausch Health Companies Inc - Key Employees
Bausch Health Companies Inc - Key Employee Biographies
Bausch Health Companies Inc - Major Products and Services
Bausch Health Companies Inc - History
Bausch Health Companies Inc - Company Statement
Bausch Health Companies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bausch Health Companies Inc - Business Description
Business Segment: Bausch + Lomb/International
Overview
Performance
Business Segment: Diversified Products
Overview
Performance
Business Segment: Ortho Dermatologics
Overview
Performance
Business Segment: Salix
Overview
Performance
Geographical Segment: US and Puerto Rico
Performance
Geographical Segment: Canada
Performance
Geographical Segment: China
Performance
Geographical Segment: Egypt
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Mexico
Performance
Geographical Segment: Others
Performance
Geographical Segment: Poland
Performance
Geographical Segment: Russia
Performance
Geographical Segment: Spain
Performance
Geographical Segment: United Kingdom
Performance
R&D Overview
Bausch Health Companies Inc - Corporate Strategy
Bausch Health Companies Inc - SWOT Analysis
SWOT Analysis - Overview
Bausch Health Companies Inc - Strengths
Bausch Health Companies Inc - Weaknesses
Bausch Health Companies Inc - Opportunities
Bausch Health Companies Inc - Threats
Bausch Health Companies Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bausch Health Companies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 06, 2019: Bausch Health Companies announces first-quarter 2019 results and raises full-year guidance
Mar 01, 2019: Synergy Pharmaceuticals receives court approval for the sale of its assets to Bausch Health
Feb 20, 2019: Bausch Health Companies announces fourth-quarter and full-year 2018 results and provides 2019 guidance
Dec 14, 2018: Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals
Nov 06, 2018: Bausch Health Companies announces third-quarter 2018 esults
Oct 30, 2018: Dr.Andrew C.Von Eschenbach joins Bausch Health Board Of Directors
Sep 28, 2018: Salix Resolves Legacy SEC Investigation With No Penalty
Sep 27, 2018: Bausch Health Releases First Annual Corporate Social Responsibility Report
Aug 03, 2018: Salix Expands Microbiome Research And Discovery Through Strategic Collaboration With Cedars-Sinai Medical Center
Jul 16, 2018: Bausch Health Companies Begins Trading As ""BHC"" On NYSE And TSX
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Bausch Health Companies Inc, Key Facts
Bausch Health Companies Inc, Key Employees
Bausch Health Companies Inc, Key Employee Biographies
Bausch Health Companies Inc, Major Products and Services
Bausch Health Companies Inc, History
Bausch Health Companies Inc, Other Locations
Bausch Health Companies Inc, Subsidiaries
Bausch Health Companies Inc, Key Competitors
Bausch Health Companies Inc, Ratios based on current share price
Bausch Health Companies Inc, Annual Ratios
Bausch Health Companies Inc, Annual Ratios (Cont...1)
Bausch Health Companies Inc, Annual Ratios (Cont...2)
Bausch Health Companies Inc, Interim Ratios
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bausch Health Companies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures


Bausch Health Companies Inc, Performance Chart (2014 - 2018)
Bausch Health Companies Inc, Ratio Charts
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bausch Health Companies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
 


Bausch Health Companies Inc. - Strategy, SWOT and Corporate Finance Report

Bausch Health Companies Inc. - Strategy, SWOT and Corporate Finance ReportBausch Health Companies Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review

Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 125

USD 125 View Report

Bausch Health Companies Inc. - Strategy, SWOT and Corporate Finance Report

Bausch Health Companies Inc. - Strategy, SWOT and Corporate Finance ReportBausch Health Companies Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Leading Animal Health Companies: Marketing Tactics, Technological Know-How and Global Sales Segment Forecasts, 2019-2023

This new report provides global animal health market outlook and leading suppliers' strategies, marketing tactics, and technological know-how. The report presents a worldwide strategic overview of the animal health market,

USD 3450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available